Funding for this research was provided by:
ministry of science and technology, taiwan (NSC98-2321-B-006-008, NSC99-2321-B-002-026, NSC100-2321-B-002-013, NSC102-2321-B-006-024, NSC101-2321-B-002-005, 107–2320-B-006 -027-MY3)
Received: 18 June 2021
Accepted: 23 September 2021
First Online: 5 October 2021
: All animal protocols were approved by the Institutional Animal Care and User Committee (NCKU-IACUC-103,146, NCKU-IACUC-104,082, and NCKU-IACUC-103,146) at National Cheng Kung University, and all animal experiments were performed by the approved guidelines and regulations.
: Not applicable.
: A patent application for the vaccine technology has been filed by C.-Y. L., M.-C. S., H.-C. C., K.-J. L., S.-K. M. K.-R. C., and P. L. All other authors declare no competing interests.